NOSTRUM PHARMA — Department of Health and Human Services SBIR Phase I: Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-
NOSTRUM PHARMA — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $224,916
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- NAICS
- —
- Place of performance
- NJ
- Period
- —
Description
Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ). PUBLIC HEALTH RELEVANCE